| Cell line name |
NZM069 |
|---|
| Synonyms |
NZM69 |
|---|
| Accession |
CVCL_0D34 |
|---|
| Resource Identification Initiative |
To cite this cell line use: NZM069 (RRID:CVCL_0D34) |
|---|
| Comments |
Omics: Transcriptomics; RNAseq. |
|---|
| Sequence variations |
|
|---|
| HLA typing |
Source: PubMed=32567790
| Class I | | HLA-A | A*01:01,25:01 | | HLA-B | B*35:03,40:01 | | HLA-C | C*03:04,12:03 |
|
|---|
| Disease |
Melanoma (NCIt: C3224) |
|---|
| Species of origin |
Homo sapiens (Human)
(NCBI Taxonomy: 9606) |
|---|
| Category |
Cancer cell line |
|---|
| Publications | PubMed=32567790; DOI=10.1111/pcmr.12908; PMCID=PMC7818249
Tran K.B., Gimenez G., Tsai P., Kolekar S., Rodger E.J., Chatterjee A., Jabed A., Shih J.-H., Joseph W.R., Marshall E.S., Wang Q., Print C.G., Eccles M.R., Baguley B.C., Shepherd P.R.
Genomic and signalling pathway characterization of the NZM panel of melanoma cell lines: a valuable model for studying the impact of genetic diversity in melanoma.
Pigment Cell Melanoma Res. 34:136-143(2021) |
|---|
| Cross-references |
|---|
| Cell line databases/resources |
cancercelllines; CVCL_0D34
|
|---|
| Encyclopedic resources |
Wikidata; Q54931607
|
|---|
| Entry history |
|---|
| Entry creation | 10-Apr-2015 |
|---|
| Last entry update | 10-Apr-2025 |
|---|
| Version number | 8 |
|---|
